Trial Profile
Clinical and cytokine responses to sublingual house dust mite allergy immunotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs House dust mite allergy immunotherapy (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- 19 Oct 2015 New trial record